Hepatitis C Virus
HIV/HCV coinfection virological responders differentiated from nonresponders
Published in AIDS Weekly, July 3rd, 2006
"PEG-IFN has become standard therapy for HCV infection. We evaluated whether PEG-IFN pharmacodynamics and pharmacokinetics account for differences in treatment outcome and whether these parameters might be predictors of therapeutic outcome," wrote A.H. Talal and colleagues, Cornell University.
"Twenty-four IFN-naive, HCV/human immunodeficiency virus-coinfected patients received PEG-IFN alpha-2b (1-5 mcg/kg) once weekly plus daily...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-07-03)
More Articles from AIDS Weekly
- HIV/AIDS Diet & Nutrition
HIV-1-infected patients need higher retinol doses to compensate for urinary loss - HIV/AIDS HAART
HAART susceptibilities determined for HIV-1 non-B subtypes - HIV/AIDS Obstetrics
Protease inhibitor-containing HAART associated with increased risk of preterm delivery - HIV/AIDS Pathogenesis
Cytotoxic T lymphocytes not responsible for majority of infected cell death in HIV/AIDS - HIV/AIDS Therapy
11 Beta-hydroxylase inhibition increases adrenal androgen secretion in HIV-infected women - Adaptive Immune Response
IFN-alpha/beta-dependent cross-priming induced by specific toll-like receptor agonists - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
